Streetbeat News

NHI

National Health Investors, Inc.

https://www.nhireit.com

Industry

REIT - Healthcare Facilities

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Open

77.07

Mkt cap

3.5B

Volume

32K

High

77.99

P/E Ratio

26.51

52-wk high

86.13

Low

76.60

Div yield

0.05

52-wk low

51.59

Titan Machinery, Precigen, Gogoro, and other major stocks experienced significant declines in Thursday's pre-market session. Titan Machinery reported weak preliminary Q2 results, leading to a 26.9% drop in its share price. Precigen, Gogoro, Snowflake, National Health Investors, Arcutis Biotherapeutics, EHang Holdings, and Emergent BioSolutions also saw notable declines.

Portfolio Pulse from Avi Kapoor

August 15, 2024 | 12:11 pm

National Health Investors (NHI) has priced an upsized public offering of 2.4 million common shares at $71.25 per share. The company has entered into forward sale agreements with BofA Securities, J.P. Morgan, Wells Fargo Securities, and BMO Capital Markets. NHI will not receive any proceeds from the sale of shares by the forward purchasers.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 6:58 am

National Health Investors (NHI) has commenced an underwritten public offering of 2 million shares.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:05 pm

Mortgage applications surged by 16.8% in the week ending Aug. 9, marking the largest one-week jump since January 2023. This increase, despite stable interest rates, led to a significant rise in refinance activity and positively impacted mortgage-linked stocks, including the iShares Residential and Multisector Real Estate ETF (REZ) and its top-performing stocks.

Portfolio Pulse from Piero Cingari

August 14, 2024 | 3:07 pm

National Health Investors (NHI) has raised its FY24 normalized FFO per share outlook from $4.37 - $4.43 to $4.52 - $4.56, surpassing the estimated $4.41.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:37 pm

National Health Investors (NYSE:NHI) reported Q2 2024 Normalized FFO of $1.18 per share, beating the analyst estimate of $1.10. Sales were $84.970 million, surpassing the $81.347 million estimate. Both FFO and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:11 pm

Truist Securities analyst Michael Lewis maintains a Hold rating on National Health Investors (NYSE:NHI) and raises the price target from $58 to $65.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 2:47 pm

Analysts have provided mixed ratings for National Health Investors (NYSE:NHI) over the past quarter, with a recent increase in the average 12-month price target to $65.0. Key analysts from Wells Fargo, Truist Securities, Wedbush, and BMO Capital have raised their price targets, reflecting a positive outlook. Despite challenges in revenue growth, NHI shows strong profitability, effective cost management, and sound financial structure.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 8:01 pm

Wells Fargo analyst James Feldman maintains an Overweight rating on National Health Investors (NYSE:NHI) and raises the price target from $63 to $69.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 5:14 pm

National Health Investors (NHI) has updated its FY24 Normalized FFO guidance from $4.31-$4.37 to $4.37-$4.43, indicating a positive adjustment in its financial outlook.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:16 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.